Avania’s Post

In the ever-changing realm of clinical trials, it is of utmost importance to guarantee effective and regulatory-compliant user acceptance testing (UAT) procedures, all the while minimizing potential risks. In this engaging webinar, leading technology vendors, 4G Clinical and Poxy Clinical, collaborated with renowned pharmaceutical company, Vir Biotechnology, Inc., to present their approach in supporting complex trial UAT. Join the speakers to gain valuable insights and strategies for enhancing UAT processes while minimizing risks. Featured Speakers: Jordan Clark, Manager, Clinical Operations, Vir Biotechnology Susan Vong, President, Poxy Clinical, UAT Services Savannah Alford, Delivery Operations Manager, 4G Clinical Laura Araujo, Vice President, Quality, 4G Clinical 🔗 https://buff.ly/3KIYuiV #RiskManagement #RiskMitigation #Compliance

Smart real-time analytics and data-driven insights: In the video, Dr. Tobias Miunske explains how our applications are revolutionizing the pharmaceutical industry and what special benefits you get from our software solutions. #innovation #machineintelligence #analytics #futureready #pynr

Introducing the next chapter in our Healthcare Use Case Series: AI in Drug Discovery! In the pharmaceutical industry, the journey from molecule discovery to FDA approval is both costly and time-consuming. With an estimated $2.6 billion spent on average per new drug, challenges abound—from intricate molecule screening processes to escalating development costs and complex clinical trials. These hurdles not only incur direct expenses but also lead to hidden indirect costs. Lengthy time-to-market, spanning nearly a decade for a new drug, results in delayed revenue streams and prolonged sales cycles. At Finarb, we're leveraging the power of data science and AI to streamline and automate drug discovery. We're driving efficiency, reducing costs, and accelerating the path to market for life-changing medications. Visit our website for more information - https://lnkd.in/eT7TFR25 Stay tuned as we're planning to share a series of impactful use cases in the healthcare sector. #HealthcareInnovation #DrugDiscovery #AIinHealthcare #DataScience

Thrilled to be featured in Sakshi Magazine, sharing my insights on how healthcare data analytics is transforming the pharmaceutical industry. Discover the future of Pharma through data-driven innovation. #HealthcareAnalytics #PharmaInnovation #AIinHealthcare #PharmaMarketing #HealthcareMarketing #MultiplierAI

Thrilled to be featured in Sakshi Magazine, sharing my insights on how healthcare data analytics is transforming the pharmaceutical industry. Discover the future of Pharma through data-driven innovation. #HealthcareAnalytics #PharmaInnovation #AIinHealthcare #PharmaMarketing #HealthcareMarketing #MultiplierAI

New regulatory frameworks like the FDA’s Breakthrough Therapy designation are speeding up drug market entry. A 2024 analysis revealed that drugs in this program had 23% shorter clinical development timelines without compromising safety. This innovation benefits patients, pharmaceutical companies, and healthcare providers, ensuring new medicines reach those in need faster. Additionally, leveraging real-world data to monitor drug safety and effectiveness enhances patient and clinician experiences by identifying improvements based on side effects, adverse events, and prescribing patterns. Infosys Engineering Services Infosys Life Sciences BASE life science Kaleidoscope Innovation Benjamin Ko Colleen Murphy Surya Duvvuri Gurdeep Singh Rooprai Kristin Christophersen Kevin Fisher Daria Marcinkowski #HealthcareInnovation #Pharma #FDA #DrugDevelopment #PatientCare #ClinicalTrials #RealWorldData #BreakthroughTherapy #MedicalInnovation #KaleidoscopeInnovation

Enhancing late-stage clinical trials using expert KOL insights, focusing on improving decision-making, minimizing risks, and streamlining processes. This resource is essential for pharmaceutical and medical professionals seeking strategic improvements in Phase 2 and 3 trials. Join us at Xpertree to further explore these insights and connect with industry experts: https://xpertree.com/ #Pharma #AI #Healthcare #BusinessIntelligence #GenAI #Xpertree #KOLmapping #KOLtool #kolengagement #kol #dol #dolmapping #doltool #scientificinsights #scientificinsightstool #pharmaAI #pharmakol #pharmadol #kolmanagement #publicationmanagement #pubmed #pubmedinsights #manuscriptsinsights #clinicatrialinsights #clinictrialupdate #congressplanner #congressai #congressmanagement #kolcongress #congressesforkol

Did you know #clinicaltrial data could be connected to real world data at the patient level? Discover 'MEDIDATA Link', a solution enabling pharmaceutical companies and researchers to trial participants’ health data beyond the trial period to better understand the outcomes of their new treatment. A great example of how Dassault Systèmes helps people live healthier lives by combining the power of trial data and real world data! Medidata Solutions #Medidata #personalizedmedecine #innovation #lifesciences

Check out this seminar https://lnkd.in/gi2-rUUb in Nov 28 to see how a major pharma using JMP Clinical 🎈🎈

AI-driven innovations are leading to better patient outcomes and cost savings for pharmaceutical companies. Generative AI is doing this in part by optimizing clinical trials, ensuring regulatory compliance, and streamlining supply chains. AI is helping us reimagine pharma, but implementing this technology demands a commitment to building trust among all stakeholders involved—especially patients. In our latest white paper, we address the ethical questions and challenges that come hand in hand with AI in pharma. Download the white paper here 👉: https://lnkd.in/gCVBeYNs #GenAI #Customertimes #pharma